Immunoliposomes as targeted delivery vehicles for cancer therapeutics (review)

International Journal of Oncology

Volumn 11, Issue 2, 1997, Pages 325-332

  Maclean, Angela L ^a,b   Symonds, Geoff ^a,b   Ward, Robyn ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b JOHNSON AND JOHNSON   (United States)

Author keywords

Immunoliposomes; Targeted delivery

Indexed keywords

ANNAMYCIN; DOXORUBICIN; IMMUNOLIPOSOME; RETINOIC ACID; VINCRISTINE;

ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER THERAPY; DRUG DELIVERY SYSTEM; GENE THERAPY; PRIORITY JOURNAL;

EID: 0030850698     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.11.2.325     Document Type: Article

References (11)

1. Bangham AD, Standish MM and Watkins JC: Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13: 238-252, 1965.
2. Papahadjopoulos D and Miller N: Phospholipid model membranes: structural characterisation of hydrated liquid crystals. Biochim Biophys Acta 135: 624-638, 1967.
3. Lasic DD: Liposomes: from Physics to Applications. Elsevier, Amsterdam, 1993.
4. Gregoriadis G (ed): Liposome Technology. Vol. I-III. 2nd edition. CRC Press, Boca Raton, FL, 1993.
5. Ledley FD: Non-viral gene therapy. Curr Opin Biotechnol 5: 626-636, 1994.
6. Gregoriadis G: Engineering liposomes for drug delivery: progress and problems. TIBTECH 13: 527-537, 1995.
7. Chonn A and Cullis PR: Recent advances in liposomal drug-delivery systems. Curr Opin Biotechnol 6: 698-708, 1995.
8. Singhal A and Huang L: Gene therapy. Hui KM (ed). World Scientific, Singapore, pp107-129, 1994.
9. Lasic DD: The mechanism of liposome formation. Biochem J 256: 1-11, 1988.
10. Lasic DD: Liposomes. Am Sci 80: 20-31, 1992.
11. Lasic DD, Martin FJ, Gabizon A, Huang SK and Papahadjopoulos D: Sterically stabilised liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta 1070: 187-192, 1991.